MRNA
Moderna, Inc.
Healthcare · in the S&P 500 and the Nasdaq-100
📍 Cambridge, United States · See it on the company map
The shape of the figures
Each spoke is one ratio. Further out means a higher figure than more of the index — not a better one. A high P/E or high debt sits far out too, so the size of the shape is not a score.
Drag to turn the shape. Tap or point at a dot to read the figure behind it.
The figures and what each one means are below. A hollow dot means the company doesn't report that figure.
Figures from the annual reports are unavailable right now — please try again in a minute.
Key figures, against the S&P 500
Figures as of 9 Nov 2026, refreshed weekly
Each bar places this company among the S&P 500 companies that report that figure. Further right means a higher figure — not a better one. Whether higher or lower suits you depends on what you are looking for, so the bars don't add up to a score.
Valuation
P/E ratio?
-63.2x
The share price is 63.2 times the last twelve months' earnings per share.
P/E on average earnings?
—
No figure for this company.
Price / book
16.0x
The market values the company at 16 times the accounting value of its equity.
EV / EBIT?
—
No figure for this company.
Free cash flow yield?
-0.5%
Free cash flow was negative, equal to −0.5% of market value.
Profitability
Return on equity?
-34.5%
Each 100 of shareholders' money produced a loss of 34.5 of net profit.
Return on assets?
-10.0%
Each 100 of assets produced a loss of 10 of net profit.
Return on invested capital
-23.6%
Each 100 invested by lenders and owners produced a loss of 23.6 of profit.
Operating margin?
-143.5%
Operating costs exceeded sales by 143.5 per 100 of sales.
Debt
Growth
Revenue growth
-80.0%
Latest revenue is 80% below the average of earlier reported years.
Earnings growth
-9,831.0%
Latest net profit is 9,831% below the average of earlier reported years.
⚠️ Not financial advice
This is a personal project, not professional investment research. The underlying market data may be delayed or incorrect. Nothing here is a recommendation to buy or sell any security. Always do your own research and consult a qualified professional before investing.
This tool is for informational and planning purposes only. It does not constitute financial, investment, tax or legal advice. Always consult a qualified professional before making financial decisions.